Initiation of antiplatelet medication after surgical thrombectomy jeopardized arteriovenous graft longevity

Allon M Current management of vascular access. Clin J Am Soc Nephrol 2007;2(4):786–800

Feldman HI Kobrin S Wasserstein A Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996;7(4):523–535

Dixon BS Beck GJ Vazquez MA et al; DAC Study Group. Effect of dipyridamole plus aspirin on hemodialysis graft patency. N Engl J Med 2009;360(21):2191–2201

Harter HR Burch JW Majerus PW et al. Prevention of thrombosis in patients on hemodialysis by low-dose aspirin. N Engl J Med 1979;301(11):577–579

Dember LM Beck GJ Allon M et al; Dialysis Access Consortium Study Group. Effect of clopidogrel on early failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial. JAMA 2008;299(18):2164–2171

Andrassy K Malluche H Bornefeld H et al. Prevention of p.o. clotting of av. cimino fistulae with acetylsalicyl acid. Results of a prospective double blind study. Klin Wochenschr 1974;52(7):348–349

Nikam MD Ritchie J Jayanti A et al. Acute arteriovenous access failure: long-term outcomes of endovascular salvage and assessment of co-variates affecting patency. Nephron 2015;129(4):241–246

Yevzlin AS Conley EL Sanchez RJ Young HN Becker BN Vascular access outcomes and medication use: a USRDS study. Semin Dial 2006;19(6):535–539

Coleman CI Tuttle LA Teevan C Baker WL White CM Reinhart KM Antiplatelet agents for the prevention of arteriovenous fistula and graft thrombosis: a meta analysis. Int J Clin Pract 2010;64(9):1239–1244

Dixon BS Beck GJ Dember LM et al; Dialysis Access Consortium (DAC) Study Group. Use of aspirin associates with longer primary patency of hemodialysis grafts. J Am Soc Nephrol 2011;22(4):773–781

Irish A Dogra G Mori T et al. Preventing AVF thrombosis: the rationale and design of the Omega-3 fatty acids (Fish Oils) and Aspirin in Vascular access OUtcomes in REnal Disease (FAVOURED) study. BMC Nephrol 2009;10(1):1

Bech FR Chertow GM Aspirin and arteriovenous graft thrombosis in hemodialysis: just what the doctor ordered? J Am Soc Nephrol 2011;22(4):595–597

Romano PS Roos LL Jollis JG Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46(10):1075–1079 discussion 1081-1090.

Charlson ME Pompei P Ales KL MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373–383

Raux M Patel VI Cochennec F et al. A propensity-matched comparison of outcomes for fenestrated endovascular aneurysm repair and open surgical repair of complex abdominal aortic aneurysms. J Vasc Surg 2014;60(4):858–863 discussion 863-864.

Green LD Lee DS Kucey DS A metaanalysis comparing surgical thrombectomy, mechanical thrombectomy, and pharmacomechanical thrombolysis for thrombosed dialysis grafts. J Vasc Surg 2002;36(5):939–945

Kakisis JD Avgerinos E Giannakopoulos T Moulakakis K Papapetrou A Liapis CD Balloon angioplasty vs nitinol stent placement in the treatment of venous anastomotic stenoses of hemodialysis grafts after surgical thrombectomy. J Vasc Surg 2012;55(2):472–478

Yeh CH Huang TS Wang YC et al. Effects of antiplatelet medication on arteriovenous fistula patency after surgical thrombectomy. Curr Vasc Pharmacol 2016;14(4):353–359

al-Momen AK Huraib SO Low-dose danazol for vascular access and dialyzer thrombosis in hemodialysis patients. Haemostasis 1992;22(1):12–16

Munda R First MR Alexander JW Linnemann CC Jr Fidler JP Kittur D Polytetrafluoroethylene graft survival in hemodialysis. JAMA 1983;249(2):219–222

Palder SB Kirkman RL Whittemore AD Hakim RM Lazarus JM Tilney NL Vascular access for hemodialysis. Patency rates and results of revision. Ann Surg 1985;202(2):235–239

Raju S PTFE grafts for hemodialysis access. Techniques for insertion and management of complications. Ann Surg 1987;206(5):666–673

Sreedhara R Himmelfarb J Lazarus JM Hakim RM Anti-platelet therapy in graft thrombosis: results of a prospective, randomized, double-blind study. Kidney Int 1994;45(5):1477–1483

Weiss MF Scivittaro V Anderson JM Oxidative stress and increased expression of growth factors in lesions of failed hemodialysis access. Am J Kidney Dis 2001;37(5):970–980

Kaegi A Pineo GF Shimizu A Trivedi H Hirsh J Gent M Arteriovenous-shunt thrombosis. Prevention by sulfinpyrazone. N Engl J Med 1974;290(6):304–306

Torsney E Mayr U Zou Y Thompson WD Hu Y Xu Q Thrombosis and neointima formation in vein grafts are inhibited by locally applied aspirin through endothelial protection. Circ Res 2004;94(11):1466–1473

Dichtl W Dulak J Frick M et al. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 2003;23(1):58–63

Mattingly RR Gibbs RA Menard RE Reiners JJ Jr. Potent suppression of proliferation of a10 vascular smooth muscle cells by combined treatment with lovastatin and 3-allylfarnesol, an inhibitor of protein farnesyltransferase. J Pharmacol Exp Ther 2002;303(1):74–81

Yamakawa T Tanaka S Kamei J Kadonosono K Okuda K Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signal-regulated kinases 1/2. J Atheroscler Thromb 2003;10(1):37–42

Gradzki R Dhingra RK Port FK Roys E Weitzel WF Messana JM Use of ACE inhibitors is associated with prolonged survival of arteriovenous grafts. Am J Kidney Dis 2001;38(6):1240–1244

Horiuchi M Cui TX Li Z Li JM Nakagami H Iwai M Fluvastatin enhances the inhibitory effects of a selective angiotensin II type 1 receptor blocker, valsartan, on vascular neointimal formation. Circulation 2003;107(1):106–112

Huang P Hawthorne WJ Peng A Angeli GL Medbury HJ Fletcher JP Calcium channel antagonist verapamil inhibits neointimal formation and enhances apoptosis in a vascular graft model. Am J Surg 2001;181(6):492–498

Jinno T Iwai M Li Z et al. Calcium channel blocker azelnidipine enhances vascular protective effects of AT1 receptor blocker olmesartan. Hypertension 2004;43(2):263–269

Palmer SC Di Micco L Razavian M et al. Antiplatelet therapy to prevent hemodialysis vascular access failure: systematic review and meta-analysis. Am J Kidney Dis 2013;61(1):112–122